Clinical Study

Pycnogenol® Normalizes Cardio Risks During Perimenopause

Published

Format: PDF file | Document type: Clinical Study

Luzzi

Related categories: Cardiovascular health

A new study builds upon previous research showing the benefits of Pycnogenol®​ for alleviating perimenopause symptoms and is the first study to show effects on cardiovascular risk markers, homocysteine and CRP levels.

Daily Pycnogenol®​ supplementation reduced and normalized elevated cardiovascular risk factors often related to perimenopause: cholesterol, triglycerides, blood pressure and blood glucose. Participants also reported significant relief of hot flashes, reduction of night sweats and mood improvement.

Related resources from Horphag Research (USA) Inc.

Show more

Supplier info centre